Chapman University Partners with the Center for Autism and Related Disorders
LOS ANGELES (June 3, 2014) – Chapman has signed a formal agreement to collaborate with the Center for Autism and Related Disorders (CARD), one of the world’s largest organizations treating autism spectrum disorder (ASD) and the third largest non-governmental organization contributing to autism research in the United States. The goal of the partnership is to advance the understanding of autism and refine current treatment strategies.
In this collaboration, Chapman and CARD® will analyze millions of data points collected during evidence-based treatment of individuals diagnosed with ASD. Chapman’s Erik Linstead, Ph.D., assistant professor at the School of Computational Sciences, and CARD’s chief strategy officer, Dennis Dixon, Ph.D., will lead a team to data mine de-identified patient data to look for patterns that could make autism treatment more effective.
“This collaboration is unique in the scope of the research and analysis in terms of the volume of data being mined,” said Daniele Struppa, chancellor, Chapman University.
The CARD® Model, which was developed over the past 24 years by leading experts in autism treatment, uses applied behavior analysis (ABA) to treat individuals diagnosed with ASD and assesses patients in every area of human functioning to identify developmental delays, challenging behaviors, and the most appropriate targets for skill acquisition. The de-identified data from these comprehensive assessments and subsequent treatment are contained in the CARD® database, and the work being done through the Chapman-CARD® partnership will seek to identify trends in the data that are likely to inform autism treatment decisions and optimize treatment outcomes while improving cost-effectiveness. Such data analysis is especially attractive in an age where research dollars are limited in that meaningful progress can be made without funding cost-prohibitive clinical trials.
“Quality ABA programs collect large sums of data naturally through the course of treatment, and those data may contain answers to many of our most pressing research questions,” said Dr. Dixon. “By collaborating with Chapman to analyze these data, we have the potential to broaden our understanding of autism treatment and the variables that contribute to its effectiveness.”
According to the Centers for Disease Control and Prevention (CDC), ASD is a group of developmental disabilities that can cause significant social, communication and behavioral challenges. About one in 68 individuals has been identified with ASD according to estimates from CDC’s Autism and Developmental Disabilities Monitoring Network. Autism spectrum disorder is almost five times more common among boys (one in 42) than among girls (one in 189), and is reported to occur in all racial, ethnic, and socioeconomic groups.
About Chapman University
Consistently ranked among the top universities in the West, Chapman University provides a uniquely personalized and interdisciplinary educational experience to highly qualified students. Our programs encourage innovation, creativity and collaboration, and focus on developing global citizen-leaders who are distinctively prepared to improve their community and their world. For more information, visit www.chapman.edu. Follow us on Facebook at: Chapman University Facebook
On Twitter at: @ChapmanU
On YouTube at: Chapman University YouTube Channel
About Center for Autism and Related Disorders (CARD)
CARD® treats individuals of all ages who are diagnosed with autism spectrum disorder (ASD) at its 26 treatment centers around the globe. CARD® was founded in 1990 by leading autism expert and clinical psychologist Doreen Granpeesheh, PhD, BCBA-D. CARD® treats individuals with ASD using the principles of applied behavior analysis (ABA), which is empirically proven to be the most effective method for treating individuals with ASD and recommended by the American Academy of Pediatrics and the US Surgeon General. CARD® employs a dedicated team of over 1,500 individuals across the nation and internationally. For more information, visit www.centerforautism.com.